Findings lay groundwork for human clinical trial planned for August 2016
A new scientific study has identified why colorectal cancer cells depend on a specific nutrient, and a way to starve them of it. Over one million men and women are living with colorectal cancer in the United States. The National Cancer Institute estimates 4.5% of all men and women will be diagnosed with the cancer during their lifetime, making it the third most common non-skin cancer.
In the study published online in Nature Communications, researchers showed how certain colorectal cancer cells reprogram their metabolism using glutamine, a non-essential amino acid. Many cancer cells rely on glutamine to survive. How they become so dependent on the molecule is hotly debated in the field.
Researchers studied a subset of colorectal cancer cells containing a genetic mutation called PIK3CA. This mutation is located in a gene critical for cell division and movement, and is found in approximately one third of all colorectal cancers. The mutation is also the most commonly identified genetic mutation across all cancers, making the results of the study universally appealing.
Researchers were interested in determining whether or not the common PIK3CA mutation contributes to changes in cancer cell metabolism, such as how nutrients like glutamine are processed. Normally, glutamine is broken down by cancer cells into several other molecules with the help of specific enzymes. This complicated system helps produce adenosine triphosphate, the energy currency of all cells, and other molecules critical for colorectal cancer cell growth.
The researchers found that colorectal cells with the PIK3CA mutation broke down significantly more glutamine than cells without the mutation. The researchers identified several enzymes involved in the process that are more active in the mutant cancer cells than in other cell types, explaining the increased need for glutamine. These enzymes become overactive in the mutant cancer cells due to a cascade of signals led by the protein encoded by mutant PIK3CA gene. This finding represents a novel and important link between the common PIK3CA mutation and altered glutamine metabolism in cancer cells.
Zhenghe John Wang, PhD, professor of genetics and genome sciences and co-leader of the Cancer Genetics Program at Case Western Reserve University School of Medicine helped lead the study. “In layman’s terms, we discovered that colon cancers with PIK3CA oncogenic mutations are addicted to glutamine, a particular nutrient for cancer cells. We also demonstrated that these cancers can be starved to death by depriving glutamine with drugs.”
When the researchers lowered the amount of glutamine available to mutant cancer cells growing in laboratory dishes, the cancer cells died. This discovery led the team to investigate the effects of blocking glutamine availability in mice with colorectal cancer tumors containing the common PIK3CA mutation. Wang and colleagues found that exposing these mice to a compound that blocks glutamine metabolism consistently suppressed tumor growth. They did not observe the same effect on tumors without the mutation. Together, these results provide a promising new therapeutic avenue to suppress growth of colorectal tumors with the PIK3CA mutation. The researchers have filed a patent application based on the unique mechanism of tumor suppression they have identified and the work is available for licensing.
“This study provides the basis for a colon cancer treatment clinical trial that will be started in the summer at the University Hospitals Seidman Cancer Center,” according to Neal Meropol, MD, Dr. Lester E. Coleman, Jr. Professor of Cancer Research and Therapeutics, chief of the division of hematology and oncology, and principal investigator for the trial. The phase I/II study will test the effects of a glutamine metabolism inhibitor in patients with advanced colorectal tumors.
The Latest on: Colorectal cancers
via Google News
The Latest on: Colorectal cancers
- Eating just one slice of bacon a day linked to higher risk of colorectal cancer, says study on April 17, 2019 at 8:53 pm
A new study finds that eating just one slice of bacon a day could increase the risk of developing colorectal cancer, CNN reports. Researchers in England tracked half of a million adults for five ... […]
- Dr. Fakih on Immunotherapy in MSS Colon Cancer on April 17, 2019 at 2:03 pm
Marwan Fakih, MD, professor, Department of Medical Oncology and Therapeutics Research, associate director for Clinical Investigations, Comprehensive Cancer Center, medical director, Judy and Bernard ... […]
- Microbial Signature for Colorectal Cancer Identified Using Machine Learning on April 17, 2019 at 11:10 am
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, the University of Trento in Italy, and other international collaborators leveraged a machine learning ... […]
- IDIBELL -- ICO researchers set new bases to develop therapies against colorectal cancer on April 17, 2019 at 9:45 am
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ProCURE program), led by Dr. David G. Molleví with Dr. Natalia Guillén Díaz-Maroto as the ... […]
- News briefs: Crime watch meeting, colon cancer, coffee with a cop on April 17, 2019 at 3:30 am
HAMMOND — Join the South Hammond Crime Watch Meeting at 7 p.m. April 18 in the Hammond Housing Authority conference room, 1402 173rd St. Hammond Community Resource Officer Butch Logan will be featured ... […]
- Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer prevention on April 17, 2019 at 2:22 am
In conventional research methods for cancer prevention, cell proliferation and apoptosis have been intensively targeted rather than the protection of normal or benign tumor cells from malignant ... […]
- Here is What You Need to Know About Colorectal Cancer on April 16, 2019 at 10:13 pm
Colon cancer can be treated if detected at an earlier stage (Photo Credit: Getty Images) Colorectal cancer claims millions of lives every year across the world. It is one of the top 3 most common ... […]
- NJ urging screenings for lung, colorectal cancers on April 16, 2019 at 5:43 pm
ScreenNJ is a public awareness campaign to reduce cancer in the state by promoting routine screenings, especially for lung and colorectal cancers. ScreenNJ Director Anita Kinney says the awareness ... […]
- Woman treated for colorectal cancer has donated blood to thank for saving her life on April 16, 2019 at 3:39 pm
A local woman is sharing her story so others will take the time to give the gift of life. Back in 2004, Kathy Sansone wasn't feeling well. Turns out she had colorectal cancer. Before she could ... […]
- Low tumour PPM1H indicates poor prognosis in colorectal cancer via activation of cancer-associated fibroblasts on April 15, 2019 at 3:07 pm
Vimentin (VIM) is considered a prognostic marker in colorectal cancer (CRC). Our aim is to identify genes that fulfil a “X-low implies VIM-high” Boolean relationship and to evaluate their prognostic ... […]
via Bing News